Drawing for IRAC

USPTO serial 99897042

IRAC

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with IRAC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Patrick J. Concannon

Patrick J. Concannon Nutter, McClennen & Fish, LLPSeaport West, 155 Seaport BoulevardBoston, MA 02210United States

Goods and services

ClassDescriptionStatusFirst use
005Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations for suppressing tumors; Vaccines; Vaccine preparations; Pharmaceutical products for the prevention and treatment of cancer; Anti-cancer preparations; Pharmaceutical preparations for the treatment of viral diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer; Biological preparations for the prevention and treatment of cancer; Pharmaceutical preparations, namely, antiviralsACTIVE—
042Pharmaceutical research and development; Research and development of pharmaceutical preparations for treating malignant tumours; Technical research in the field of pharmaceutical studies; Development of pharmaceutical preparations and medicines; Scientific research for medical purposes in the field of cancerous diseases; Medical research; Providing scientific research information in the field of pharmaceuticals; Scientific study and research in the field(s) of medicine; Research and development services in the field of medical preparations; Research and development of new products in the field of pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 22, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 22, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance